Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines the establishment of a collaborative partnership aimed at leveraging their respective resources and expertise.
This MOU signifies the “unwavering commitment” of both organisations to revolutionise prehospital workflow through the implementation of an artificial intelligence (AI)-driven clinical decision support and workflow solution. As per a press release, the primary focus of this partnership will initially be directed towards enhancing acute stroke services.
Nicolab specialises in cutting-edge technology for digital telehealth services, particularly in stroke diagnosis and triage, exemplified by its StrokeViewer product, while Titan is a leading healthcare research company that specialises in delivering digital health technologies and AI-powered clinical decision assistance technologies. The latter’s digital telestroke platform, Zeus, integrates essential features, such as online clinical forms, patient geo-tracking, direct ambulance-to-neurologist communication, and enables rapid triage for stroke patients.
Bringing together Nicolab’s StrokeViewer solution and Titan’s Zeus solution “sets the foundation for a revolutionary approach” to diagnosing, assessing and treating stroke, and other acute diseases, the release also states. By combining their efforts, the two companies aim to equip healthcare professionals with an innovative tool that empowers them to make faster, more accurate decisions, ultimately saving lives and reducing long-term disabilities.
“We are thrilled to embark on this transformative journey,” said Michael Macilquham, chief commercial officer at Nicolab. “Together, we share a vision of how our disruptive technology will shape the future of healthcare and revolutionise prehospital workflow.”
“This development highlights the immense potential of Australian industry and medical research partnerships to drive technology innovation in the prehospital space,” added Titan co-founder Mark Parsons. “Early in 2023, we were pleased to see that Zeus had delivered a positive impact for acute stroke care in South Australia. We are excited to be exploring how StrokeViewer and Zeus can further transform acute care for stroke patients, and optimise health service delivery more broadly.”
